{"id":"W4391166174","doi":"10.1016/s1474-4422(23)00454-4","title":"Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study","year":2024,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":33,"is_retracted":false,"has_abstract":false,"ca_institutions":"iCo Therapeutics (Canada); University of British Columbia","funders":"Wellcome Trust; Active Biotech; European Huntington's Disease Network; Teva Pharmaceutical Industries","keywords":"Huntington's disease; Medicine; Placebo; Clinical endpoint; Internal medicine; Adverse effect; Physical therapy; Clinical trial; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006584117,0.0003380711,0.000875425,0.0001353982,0.0002388838,0.0001068553,0.000537515,0.00005293089,0.0000417573],"category_scores_gemma":[0.001828141,0.0002280636,0.0002264712,0.000262478,0.0003588262,0.0000910746,0.000207087,0.0002900345,0.00001672205],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007104277,"about_ca_system_score_gemma":0.0001069091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007322416,"about_ca_topic_score_gemma":0.00001184608,"domain_scores_codex":[0.9966217,0.001027994,0.0005763514,0.0009221017,0.0002922129,0.0005596614],"domain_scores_gemma":[0.9934132,0.005463774,0.0001904074,0.0006792446,0.00005893573,0.0001944903],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9597394,0.001268031,0.0005098594,0.0001244408,0.0001023547,0.00007484246,0.0006154116,0.001026197,0.03282325,0.001714426,0.0004281454,0.001573656],"study_design_scores_gemma":[0.935298,0.001829179,0.001449156,0.00002217926,0.0009015367,0.0000143215,0.00005448411,0.01713616,0.03814388,0.0003172037,0.004482178,0.0003516641],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869422,0.0004389124,0.0002819831,0.003796085,0.0006614088,0.00734608,0.0001944087,0.0001431073,0.0001958663],"genre_scores_gemma":[0.9966932,0.0001252783,0.00002070746,0.001773997,0.0004447407,0.0007082777,0.000006779156,0.00005649618,0.0001705067],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02444133,"threshold_uncertainty_score":0.9300165,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04614417203517779,"score_gpt":0.3386271924069397,"score_spread":0.2924830203717619,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}